News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,185 Results
Type
Article (41821)
Company Profile (329)
Press Release (663035)
Section
Business (210130)
Career Advice (2075)
Deals (36573)
Drug Delivery (96)
Drug Development (82796)
Employer Resources (171)
FDA (16478)
Job Trends (15357)
News (355391)
Policy (33819)
Tag
Academia (2574)
Alliances (51087)
Alzheimer's disease (1247)
Approvals (16409)
Artificial intelligence (140)
Bankruptcy (362)
Best Places to Work (11672)
Biotechnology (214)
Breast cancer (122)
Cancer (1110)
Cardiovascular disease (102)
Career advice (1737)
Cell therapy (238)
Clinical research (65786)
Collaboration (395)
Compensation (202)
COVID-19 (2601)
C-suite (96)
Data (1135)
Diabetes (154)
Diagnostics (6224)
Earnings (86506)
Employer resources (149)
Events (112341)
Executive appointments (318)
FDA (17026)
Funding (359)
Gene therapy (188)
GLP-1 (611)
Government (4445)
Healthcare (18851)
Infectious disease (2686)
Inflammatory bowel disease (110)
Interviews (319)
IPO (16580)
Job creations (4051)
Job search strategy (1487)
Layoffs (433)
Legal (8318)
Lung cancer (172)
Manufacturing (185)
Medical device (13260)
Medtech (13265)
Mergers & acquisitions (20066)
Metabolic disorders (420)
Neuroscience (1531)
NextGen Class of 2024 (6624)
Non-profit (4512)
Northern California (1489)
Obesity (242)
Opinion (203)
Patents (105)
People (58234)
Pharmaceutical (93)
Phase I (20346)
Phase II (28952)
Phase III (21715)
Pipeline (460)
Postmarket research (2644)
Preclinical (8679)
Radiopharmaceuticals (241)
Rare diseases (229)
Real estate (6240)
Regulatory (22368)
Research institute (2358)
Resumes & cover letters (358)
Southern California (1309)
Startups (3712)
United States (13673)
Vaccines (568)
Weight loss (183)
Date
Today (1)
Last 7 days (675)
Last 30 days (3492)
Last 365 days (36220)
2024 (33270)
2023 (40629)
2022 (51798)
2021 (56331)
2020 (54796)
2019 (47401)
2018 (35771)
2017 (33137)
2016 (32662)
2015 (38616)
2014 (32516)
2013 (27631)
2012 (29730)
2011 (30487)
2010 (28498)
Location
Africa (776)
Arizona (199)
Asia (39996)
Australia (6395)
California (3356)
Canada (1301)
China (257)
Colorado (150)
Connecticut (156)
Europe (85150)
Florida (462)
Georgia (116)
Illinois (348)
Indiana (204)
Kansas (96)
Maryland (581)
Massachusetts (2654)
Michigan (159)
Minnesota (274)
New Jersey (972)
New York (968)
North Carolina (720)
Northern California (1489)
Ohio (139)
Pennsylvania (852)
South America (1157)
Southern California (1309)
Texas (475)
Washington State (369)
705,185 Results for "peregrine pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Ablative Solutions, Inc. Announces Primary Endpoint Met in the TARGET BP I Pivotal Trial of the Peregrine System™ Kit for Patients with Uncontrolled Hypertension
Ablative Solutions, Inc., today announced that the TARGET BP I Pivotal Trial evaluating alcohol-mediated renal denervation with the Peregrine System ™ Kit met its primary endpoint, showing a statistically significant difference in 24-hour Ambulatory Blood Pressure between treatment and sham procedure at 3 months.
December 19, 2023
·
2 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Press Releases
Bexion Pharmaceuticals, Inc. to Participate in the Jefferies London Healthcare Conference
November 12, 2024
·
2 min read
Press Releases
Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences
November 7, 2024
·
1 min read
Genetown
Variantyx Secures $36M Investment As Testing Demand And Market Share Continues To Increase
Variantyx, a leader in molecular diagnostics, announced that it has secured an additional $36 million in funding from its portfolio of investors which includes Peregrine Ventures, Pitango HealthTech, New Era Capital Partners and Bosch Ventures.
April 26, 2024
·
2 min read
BioMidwest
Nika Pharmaceuticals, Inc. (NIKA) Presents Its Business Strategy
Nika Pharmaceuticals, Inc. introduces its plans to develop the company into a sustainable business project that will consistently grow, bring good profits and provide dividends to its shareholders.
June 3, 2024
·
5 min read
BioMidwest
Bexion Pharmaceuticals, Inc. to Present at BIO International Convention 2024
Bexion Pharmaceuticals, Inc. announced that the Company will present at the 2024 Biotechnology Innovation Organization International Convention taking place June 3-6, 2024, in San Diego, California.
May 31, 2024
·
2 min read
Press Releases
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2024 Results and Provides Business Update
November 13, 2024
·
10 min read
Deals
Future Pak Issues Enhanced and Final Proposal to Acquire Vanda Pharmaceuticals Inc.
Future Pak, LLC and its affiliates announced that it has submitted a final attempt to engage with Vanda Pharmaceuticals Inc. in a good faith effort to acquire all outstanding shares of Vanda.
June 13, 2024
·
4 min read
Press Releases
Bexion Pharmaceuticals, Inc. Awarded Grant from The Michael J. Fox Foundation to Advance BXQ-350
November 15, 2024
·
2 min read
1 of 70,519
Next
